Table 2 Study characteristics
Statistic | Category | Number of studies (%) |
|---|---|---|
Type of study | Full economic evaluation | 8 (22)a |
Partial economic evaluation | 13 (36) | |
Cost study | 7 (19) | |
Outcome study | 8 (22) | |
Study setting | Australia | 5 (14) |
Canada | 6 (17) | |
France | 1 (3) | |
Germany | 1 (3) | |
Netherlands | 5 (14) | |
Spain | 1 (3) | |
UK | 4 (11) | |
USA | 13 (36) | |
Sequencing approach | WES (humans) | 24 (67) |
WGS (humans) | 5 (14) | |
Both WES and WGS (humans) | 5 (14) | |
Bacterial WGS (pathogens) | 2 (6) | |
Study sample size | Not reported | 8 (22) |
<10 | 4 (11) | |
10–19 | 5 (14) | |
20–99 | 10 (28) | |
≥100 | 9 (25) | |
Study population | Children or newborns | 13 (36) |
Adults | 9 (25) | |
Both adults and children | 6 (17) | |
Population unclear | 2 (6) | |
No study population | 6 (17) |
